bilaterals.org logo
bilaterals.org logo

intellectual property


Don’t trade our lives away in free trade negotiations
To sign the RCEP and start negotiations on a FTA with the US when the Indian economy is on the brink of economic downturn and needs strong domestic policies is a decision that is not in national or public interest.
US farmers’ group says pharma, not dairy, is main obstacle to ratifying USMCA
The National Farmers Union says the new deal’s extended patent protection for new pharmaceuticals must be reduced so that less expensive generic versions of new drugs can be available to consumers sooner.
Seed patent protection in FTA castrated the farmers’ rights
The government of Indonesian is aggressively increasing the negotiation of international trade agreements governing seed patents for corporations.
Aussie farmers dig in to save common food names
Farmers are fighting back calling the EU’s demands on geographical indicators ‘bad policy’.
Europe seeking feta and scotch beef protection as Australia pushes back on prosecco claims
Europe’s bid to stop Australian cheesemakers using the name feta has advanced but its claim on the sparkling wine prosecco is facing growing opposition amid ongoing trade talks.
Administrative enforcement of IP: Lessons of KORUS for RCEP
KORUS grants a power to the customs authorities to suspend release of suspected counterfeit or pirated goods into free circulation when a right holder requests to do so with “adequate evidence”.
Why TRIPS-plus IPR enforcement is bad: Lessons of KORUS for RCEP
One of the main purposes of the US in bilateral negotiation is to level up the enforcement of IPRs, especially enhanced enforcement provisions that the US sought but failed in achieving at the TRIPS negotiation.
Civil enforcement of IPR: Lessons of KORUS for RCEP
The provisions for civil enforcement are to ensure to the maximum extent the economic interests of IP holders. For the full compensation for them, KORUS intervenes the way to calculate the amount of damages.
Criminal enforcement of copyright and unintended consequences: Lessons of KORUS for RCEP
Soon after the signing of the Korea-US FTA (“KORUS”) in June 2007, South Korea experienced a dramatic increase of complaints of copyright crime from 2007.
Keep agriculture and dairy out of RCEP negotiations, farmers’ body tells government
The RCEP will destroy farm livelihoods especially in the domestic dairy sector.
Japan and US break new ground on free digital trade
Japanese and American trade negotiators have reached a broad agreement on the digital economy, in which digital products are tariff-free and businesses can host servers wherever they choose.
Vietnam: New free trade agreement with EU strengthens IP protection
Vietnam’s full compliance with the EVFTA will require a comprehensive review and amendment of its intellectual property law.
Trade negotiations and the triple trouble for health and the NHS
On Monday, the British parliament will debate whether the NHS should be included in US trade talks. Here’s how to decode the reassuring words we’ll no doubt hear from government.
Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement (FTA).
India protects drug, agriculture business at RCEP
Three harmful provisions concerning pharmaceuticals and agriculture which were part of the RCEP have been withdrawn.
Thai CSOs’ proposition against IP enforcement in the RCEP negotiation
FTA Watch would like to urge the Thai negotiation team for the RCEP to have a strong position to reject proposals on Intellectual Property Enforcement chapter.
NAFTA demolition better for PBI
USMCA, a modernization of the North American Free Trade Agreement, includes several positive changes for the seed industry.
NAFTA bill lets Trudeau cabinet wait and see what US Congress does Social Sharing
US Democrats fear higher drug prices, trying to change text of trade deal
Free trade can seriously damage your health
These practises open the door to Big Pharma companies and disastrous private health companies.
PepsiCo controversy: Globally, India has always refused to give in on IPR on plant varieties
The struggle for farmers’ rights over their seeds and planting materials is not playing out only in India – it’s a global phenomena.